Editor's note: this interview was originally published on BioPharmInternational.com.
Pharmaceutical Technology on MSN
Guardant and Zephyr AI pair up to advance cancer biomarker development
Guardant Health and Zephyr AI have partnered to advance the discovery of novel cancer biomarkers, as more precise tumour ...
GlobalData on MSN
Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer
Eli Lilly and NVIDIA will build a new supercomputer to accelerate drug discovery and shorten development cycles.
SYDNEY--(BUSINESS WIRE)--Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies, ...
OXNARD, Calif.--(BUSINESS WIRE)--CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it ...
Gilead Sciences recently broke ground on a 180,000-square-foot AI-enabled Pharmaceutical Development and Manufacturing Technical Development Center at its Foster City campus, part of a US$32 billion ...
AI’s true power lies in pattern recognition across messy, real-world data: Natural language processing extracts phenotypes, comorbidities, and device usability feedback from unstructured clinical ...
Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Development and Manufacturing Organization Market Size, Share & Trends Analysis Report by Type (Small Molecule, Large Molecule), ...
insights from industrySree VadlamudiVice President, Head of Business Development EU, RoWIktos As part of our SLAS Europe 2022 coverage, we speak to Dr. Sree Vadlamudi, Vice President BD at Iktos, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results